N/A N=62 Dietary Supplement With and Without a Probiotic
Healthy Adult Subjects
Primary: Evaluation of the Levels of B.Infantis in Stool by Quantitative PCR — 3.33; 3.33; 3.33; 3.33 copies/ng DNA — p=<0.0001
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=13 Evaluation of the Ketogenic Potential of Different Diet Supplements
Healthy Adults
Primary: Concentration of Total Plasma Ketones — -18.2; 23; 12.2; 68.5 µmol/L
N/A N=92 Dietary Supplement With and Without a Probiotic and/or Antibiotic
Healthy Adults
Primary: Evaluation of the Changes in Microbiome Species Abundance and Diversity From Baseline Until End of Study (Day 35) — 27.00; 31.25; 27.00; 27.00 copies/ng DNA — p=<0.0001
N/A N=90 Dietary Supplements for the Treatment of Angelman Syndrome
Angelman Syndrome · Nervous System Diseases
Primary: Average Change in Functioning in Specific Areas of Development, Including Speech and Communications Skills, Cognitive Abilities and Daily Living Skills — 5.7; 4.7; 5.8…
N/A N=30 Impact of Nutritional Supplementation on Aerobic Performance and Fatigue
Performance · Fatigue
Primary: Perceived Exertion — 6.7; 7.4 units on a scale
N/A N=69 The Effects of the Dietary Supplement CardioFlex Q10 on Reducing Cardiovascular Disease Risk Factors in Adults
Cardiovascular Diseases · Cardiovascular Abnormalities · Heart Attack
Primary: Change From Baseline of Total Cholesterol After 90 Days — -0.57; -1.09 mmol/L — p=0.042
N/A N=10 Effect of a Dietary Supplement on Quality of Life
Quality of Life
Primary: Chubon Lifestyle Score — 103.9; 100.9; 100.4; 102.9 score on a scale
Phase 4 N=60 The Effects of Formula Diet on Body Weight, Body Composition, and Biomarkers for Disease Compared to a Standard Diet
Body Weight Changes
Primary: Body Weight Loss (kg and Percent) at Months 3 and 6
N/A N=16 Single Low-Dose of Supplement Amino Acid
Growth Hormone · Amino Acid
Primary: Change From Baseline of Growth Hormone — 1.15; -0.48 nanograms/ml — p=0.01
N/A N=62 Effects of Micronutrient (Chromium) Supplementation on Diabetes
Diabetes Mellitus, Type 1
Primary: Blood Glucose Level — 172.39; 212.85; 164.47; 191.25 mg/dL
N/A N=11 A Nutritional Supplement Capsule Containing Curcumin, Green Tea Extract, Polygonum Cuspidatum Extract, and Soybean Extract in Healthy Participants
Healthy, no Evidence of Disease
Primary: The Magnitude of Change in Blood Lymphocyte NF-kB Level — -40.51 Optical Density unit
N/A N=35 Fiber and Fish Oil Supplements for the Prevention of Colorectal Cancer
Healthy Subject
Primary: Feasibility and Retention for a Trial With Daily Doses of 35 g of Fiber and 6.2 g of EPA +DHA (and Corresponding Comparators) — 14; 15; 1; 1 Participants
N/A N=60 A Study to Evaluate the Effects of a Dietary Supplement on Children's Health and Development Outcomes.
Height · Cognitive Function · Weight Gain
Primary: Change Mean Percentile Score in Double Trouble — 168.55; 129.46 percent change from baseline — p=0.488445
Phase 4 N=53 Effect of Calcium + Vitamin D Supplementation on Weight Management in Very-low Calcium Consumers
Obesity · Overweight
Primary: Change in Body Weight — -3.9; -3.5 kg — p=0.441
N/A N=80 Study Evaluating the Effects of Dietary Supplement on Hair Thickness and Hair Strength in Individuals With Self-Perceived Thinning Hair
Hair Thinning
Primary: Hair Shedding (1-2 Hairs Per Unit) — 21; 10 Participants
Phase 4 N=300 Nutrition, Physical Performance & Fitness in Indian School Children
Physical Fitness · Nutritional Status
Primary: Change From Baseline in Maximal Aerobic Capacity (VO2max)- 12 Inch Step Test After 4 Months — 36.8; 37.9; 37.0; 38.9 mL/kg/min. — p=0.004
Phase 1 N=10 A Phased Clinical Trial of Dietary Supplemental Kava: Kava Pharmacokinetics
Pharmacokinetics
Primary: Time to Maximum Concentration of Kava in the Blood — 1.9; 1.2; 1.3; 1.2 hours
N/A N=57 Oxidized Omega-3 Supplements With Different Oxidation
Overweight
Primary: Weight (Kilogram) of Volunteers at the Beginning (Day 1) and at the End of the Study (Day 30) — 70.17; 68.77; 75.15; 69.38 kilogram
Phase 2 N=208 The Effect of Protein Supplementation on Bone Health in Healthy Older Men and Women
Bone Resorption · Osteoporosis
Primary: Change in Anterior-posterior Spine Bone Mass Density Measured by Dual Energy X-ray Absorptiometry (DXA) Compared to Baseline — 0.51; 0.51 percentage change
N/A N=352 Clinical Trial of Dietary Protein and Blood Pressure
Cardiovascular Diseases · Hypertension · Heart Diseases
Primary: Change From Baseline in Average Systolic Blood Pressure at 8 Weeks — -1.5; -1.8; 0.5 mmHg
Phase 3 N=74 Micronutrient Supplementation in Patients With Heart Failure
Heart Failure
Primary: Left Ventricular Ejection Fraction — 44.7; 38.9; 44.9; 38.6 percentage of LVEF
Phase 3 N=4,203 Age-Related Eye Disease Study 2 (AREDS2)
Age-related Macular Degeneration · Cataract
Primary: Development of Advanced AMD in People at Moderate to High Risk for Progression. — 493; 468; 507; 472 Eyes — p=<0.013
Phase 2 N=54 Dietary Treatment of Crohn's Disease
Crohn's Disease · Inflammatory Bowel Disease
Primary: Number of Participants With Flare Up of Crohn's Disease Through Month 12 — 6; 4; 0 participants
N/A N=70 Effect of Dietary Supplemental Fish Oil in Alleviating Health Hazards Associated With Air Pollution
Oxidative Stress · Inflammation · Blood Pressure
Primary: Biomarkers of Antioxidant Activity-Total Antioxidant Capacity (TAC) and Superoxide Dismutase (SOD) — 6.09; 5.80; 364.34; 356.59 U/ml
N/A N=51 Physiological Effects of Nutritional Support in Patients With Parkinson's Disease
Parkinson Disease · Idiopathic Parkinson Disease
Primary: Distribution Volume Ratio — 2.65; 2.70; 2.96; 2.74 Distribution volume ratios — p=0.05
N/A N=56 Vitamin D Supplementation in Healthy Adolescents
Vitamin D Supplementation
Primary: Baseline 25 Hydroxy Vitamin D (25OHD) Levels — 28.1; 29 ng/ml
N/A N=3,424 A Large Randomized Trial of Vitamin D, Omega-3 Fatty Acids and Cognitive Decline
Cognitive Decline
Primary: Change in Global Composite Score for Cognitive Decline — -0.24; -0.25; -0.25; -0.24 Z-score — p=0.31
N/A N=266 Nutritional Supplements and Hormonal Manipulations for Breast Cancer Prevention
Breast Cancer
Primary: Change in Absolute Breast Density — 65.53; 64.39; 65.08; 56.35 cm squared
N/A N=24 Omega-3 Supplementation and Resistance Training
Sarcopenia · Dynapenia · Inflammation
Primary: Tumor Necrosis Factor-alpha — 1.05; 0.93; 1.04; 1.18 pg/mL
Phase 2 N=92 Vitamin D and Calcium Homeostasis for Prevention of Type 2 Diabetes
Glucose Intolerance · Type 2 Diabetes Mellitus · Metabolic Syndrome
Primary: Chang in Disposition Index, a Measure of Beta Cell Function — 287; 314; -122; -129 units on a scale